These include Bravecto, Credelio, Nexgard and Simparica.
The U.S. Food and Drug Administration (FDA) issued a new warning this past week alerting pet owners and veterinarians of the potential for muscle tremors, ataxia and seizures in dogs and cats when treated with flea and tick drugs that are in the isoxazoline class. These include Bravecto, Credelio, Nexgard and Simparica.
These products are approved for the treatment and prevention of flea infestations, and the treatment and control of tick infestations.
Although the FDA says these products can and have been safely used in the majority of dogs and cats, it recommends pet owners consult with their veterinarian to review their patients’ medical histories and determine whether a product in the isoxazoline class is appropriate for their pet.
The FDA says it is working with manufacturers of isoxazoline products to include new label information to highlight adverse neurologic events because these events were seen consistently across the isoxazoline class of products.
Most Read Nation & World Stories
- At least 13 people arrested at Portland, Oregon, protest VIEW
- 'CBS Evening News' anchor Norah O'Donnell caught on hot mic during Plácido Domingo segment saying 'Sounds like somebody else here'
- 2 Blue Angels planes touch during midair practice run
- Woman thought she had kidney stones, gave birth to triplets
- Java still a no-no for Mormons despite fancy coffee names
For more information, read here.